Last reviewed · How we verify
sperm capacitation
At a glance
| Generic name | sperm capacitation |
|---|---|
| Sponsor | Assaf-Harofeh Medical Center |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of a New Sperm Capacitation Method
- Capacitation-associated Protein Tyrosine Phosphorylation As a Possible Biomarker of Sperm Selection (NA)
- Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy. (NA)
- Sperm Selection by Rheotaxis and Thermotaxis in In-Situ Handmade Microfluidics of Fluidic Walls in the Same ICSI Plate
- Preterm Delivery After Septum Resection
- Hypotaurine Supplementation Benefits in Cryopreservation
- Intrauterine Insemination Predictor Factors
- Magnetic Activated Cell Sorting in Artificial Insemination With Donor Sperm (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- sperm capacitation CI brief — competitive landscape report
- sperm capacitation updates RSS · CI watch RSS
- Assaf-Harofeh Medical Center portfolio CI